Puma Biotechnology, Inc.PBYINASDAQ
Loading
Cash Flow PerformanceStrong
Percentile Rank100
Studio
Year-over-Year Change

Operating cash flow minus capital expenditures

Percentile
P100
Near historical high
vs 2Y Ago
2.9x
Strong expansion
Streak
3 yr
Consecutive growthStrong
PeriodValueYoY Change
TTM$41.73M+7.4%
2024$38.86M+170.5%
2023$14.37M+162.9%
2022$-22.83M-210.5%
2021$20.65M+207.3%
2020$-19.25M-187.2%
2019$22.07M+189.3%
2018$-24.71M+88.9%
2017$-222.93M-49.6%
2016$-148.98M-